Last checked at 14 May 2021 16:00
SMITH & NEPHEW PLC
14 May 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2020 final dividend payment on 12 May 2021. |
Date of Transaction | 2021 - 05 - 12 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) | Director / PDMR | Price | Volume | Aggregated information | Total Ordinary Share Holding following the transaction * | Total Ordinary Share Holding as a % of the Company's ISC following the transaction * |
Bradley Cannon (President Sports Medicine & ENT) | PDMR | £15.269779 | 129.64031 | N/A Single Transaction | 77,295.40344 (including 2,101.64550 in ADS') | 0.00873% |
Phil Cowdy (Chief Business Development & Corporate Affairs Officer) | PDMR | £15.269779 | 112.08811 | N/A Single Transaction | 45,410.28786 | 0.00513% |
Myra Eskes (President APAC Region) | PDMR | £15.269779 | 197.38513 | N/A Single Transaction | 18,332.32816 | 0.00207% |
Simon Fraser (President Advanced Wound Management) | PDMR | £15.269779 | 92.76422 | N/A Single Transaction | 8,615.56333 | 0.00097% |
Mark Gladwell (President Operations & GBS) | PDMR | £15.269779 | 96.46099 | N/A Single Transaction | 96.90438 | 0.00001% |
Melissa Guerdan (Chief Quality & Regulatory Affairs Officer) | PDMR | £15.269779 | 99.85666 | N/A Single Transaction | 9,274.28002 | 0.00105% |
Skip Kiil (President Orthopaedics) | PDMR | £15.269779 | 99.50036 | N/A Single Transaction | 12,128.03780 | 0.00137% |
Catheryn O'Rourke (Chief Legal & Compliance Officer) | PDMR | £15.269779 | 583.31782 | N/A Single Transaction | 82,100.55347 (including 5,818.25734 in ADS') | 0.00928% |
Susan Swabey (Company Secretary) | PDMR | £15.269779 | 190.40720 | N/A Single Transaction | 49,416.24672 | 0.00558% |
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410